We further analyzed ERFE expression in CD71+ cells of a larger cohort of MDS patients (n=111) and healthy controls (n=52), where it was shown that ERFE expression was significantly upregulated in low/int-1 MDS, which corresponds to the increased ERFE expression in MDS as shown by Miura et al. This evidence concerns the gene TFRC and myelodysplastic syndrome.